Quetiapine for bipolar depression: a systematic review and meta-analysis
The DOI matches its Crossref record.
Abstract
Quetiapine has been proposed for depression in bipolar patients but a quantitative analysis is lacking. In the present paper, we review and meta-analyze available data about the short-term and long-term efficacy and tolerability of quetiapine for the depressive phase of bipolar disorder or bipolar depression. A literature research was carried out using three electronic databases. Studies providing measures of efficacy and tolerability of quetiapine, either as monotherapy or as augmentation, for bipolar depression were considered. Seven short-term studies and four maintenance studies were included. Short-term studies suggested that patients treated with quetiapine monotherapy were significantly more likely than patients treated with placebo and further active comparators to achieve higher response and remission rates as well as more clinical improvements at the endpoint. Such benefits were significant from the first weeks of treatment onward. Maintenance studies suggested that the combination of quetiapine and mood stabilizers was significantly better than placebo plus mood stabilizers for the prevention of both depressive and manic relapses. Quetiapine was generally well tolerated. Furthermore, several clinical variables moderated outcomes under investigation. In conclusion, quetiapine could have some advantages over traditional treatments for the treatment of bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amongst the first‐line options recommended, quetiapine and lurasidone have separated from placebo in clinical trials at as early as week 1.249, 307, 308”
Citations
Cites
Still being checked.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“It appears that some mood stabilisers may have greater efficacy during the depressive phase, therefore consideration of adding or switching to such agents is advisable (Chiesa et al., 2012; De Fruyt et al., 2012; Van Lieshout and MacQueen, 2010).”
BackgroundBahji, A., Ermacora, D., Stephenson, C., Hawken, E. R., & Vazquez, G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.030 · Cited by 139
Therapeutic Drug Monitoring of Common Antipsychotics
Patteet, L., Morrens, M., Maudens, K. E. K., Niemegeers, P., Sabbe, B., & Neels, H. M. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182708ec5 · Cited by 113
The treatment of psychotic depression: Is there consensus among guidelines and psychiatrists?
Leadholm, A., Rothschild, A. J., Nolen, W. A., Bech, P., Munk‐Jørgensen, P., & Østergaard, S. D. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.036 · Cited by 65
Metadata
- Authors
- Chiesa, A., Chierzi, F., De Ronchi, D., & Serretti, A.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Serretti, Alessandro
- Venue
- International Clinical Psychopharmacology
- Published
- 2012-03
- Volume
- 27
- Issue
- 2
- Pages
- 76-90
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2012661386
- Cited by
- 45
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2022: 3 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 5 · 2013: 3 · 2012: 11
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- quetiapine, bipolar depression, bipolar disorder, atypical antipsychotics, monotherapy, augmentation therapy, mood stabilizers, maintenance therapy, relapse prevention, treatment efficacy, tolerability
- MeSH terms
- Quetiapine Fumarate, Adolescent, Adult, Antidepressive Agents, Bipolar Disorder, Child, Dibenzothiazepines, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Norepinephrine, Serotonin Antagonists, Time Factors, Antipsychotic Agents, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quetiapine for bipolar depression: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/yic.0b013e32834e4c56
- The paper
- Chiesa, A., Chierzi, F., De Ronchi, D., & Serretti, A. (2012). Quetiapine for bipolar depression: a systematic review and meta-analysis. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e32834e4c56
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.